Comparative Benchmarking
In the context of the broader market, OKYO competes directly with industry leaders such as ICCC and OSTX. With a market capitalization of $85.54M, it holds a significant position in the sector. When comparing efficiency, OKYO's gross margin of N/A stands against ICCC's 44.97% and OSTX's N/A. Such benchmarking helps identify whether OKYO Pharma Ltd is trading at a premium or discount relative to its financial performance.
